PT1083884E - Processo para a estabilizacao de composicoes de polivinil-pirrolidona - Google Patents

Processo para a estabilizacao de composicoes de polivinil-pirrolidona

Info

Publication number
PT1083884E
PT1083884E PT00917004T PT00917004T PT1083884E PT 1083884 E PT1083884 E PT 1083884E PT 00917004 T PT00917004 T PT 00917004T PT 00917004 T PT00917004 T PT 00917004T PT 1083884 E PT1083884 E PT 1083884E
Authority
PT
Portugal
Prior art keywords
stabilization
polyvinyl
small amounts
pyrrolidone
compositions
Prior art date
Application number
PT00917004T
Other languages
English (en)
Inventor
Volker Buhler
Ulrich Filges
Tanja Schneider
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of PT1083884E publication Critical patent/PT1083884E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • C08K2003/0843—Cobalt
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • C08K2003/085—Copper
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/02—Elements
    • C08K3/08—Metals
    • C08K2003/0893—Zinc

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
PT00917004T 1999-04-06 2000-03-28 Processo para a estabilizacao de composicoes de polivinil-pirrolidona PT1083884E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19915420A DE19915420A1 (de) 1999-04-06 1999-04-06 Stabilisierte Polyvinylpyrrolidon-Zubereitungen

Publications (1)

Publication Number Publication Date
PT1083884E true PT1083884E (pt) 2003-02-28

Family

ID=7903617

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00917004T PT1083884E (pt) 1999-04-06 2000-03-28 Processo para a estabilizacao de composicoes de polivinil-pirrolidona

Country Status (10)

Country Link
US (1) US6592900B1 (pt)
EP (1) EP1083884B1 (pt)
JP (1) JP2002541091A (pt)
CN (1) CN1174743C (pt)
AT (1) ATE226066T1 (pt)
DE (2) DE19915420A1 (pt)
DK (1) DK1083884T3 (pt)
ES (1) ES2185584T3 (pt)
PT (1) PT1083884E (pt)
WO (1) WO2000059478A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4573998B2 (ja) * 2000-11-17 2010-11-04 株式会社日本触媒 ビニルピロリドン系重合体粉体の製造方法
US20030118647A1 (en) * 2001-12-04 2003-06-26 Pawan Seth Extended release tablet of metformin
AU2004275835B2 (en) * 2003-09-26 2011-06-23 Alza Corporation Controlled release formulations exhibiting an ascending rate of release
CN102697704A (zh) * 2003-09-26 2012-10-03 阿尔扎公司 阿片类与非阿片类镇痛药的控释制剂
WO2005072079A2 (en) * 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same
EP1663145B1 (en) * 2003-09-26 2011-04-06 ALZA Corporation Oros-push-stick for controlled delivery of active agents
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
DE102005005974A1 (de) * 2005-02-09 2006-08-10 Basf Ag Verfahren zur Stabilisierung von Polyvinylpyrrolidonen
DE102005018465A1 (de) * 2005-04-20 2006-11-02 Basf Ag Bindemittel für Tabletten mit hoher Festigkeit auf Basis von Herstellung und Verwendung von feinteiligen Vinyllactampolymerenn, deren Herstellung und Verwendung
JP4809194B2 (ja) * 2006-11-15 2011-11-09 株式会社日本触媒 ビニルピロリドン系重合体粉末の製造方法
DE202009000692U1 (de) 2008-11-04 2009-04-16 Basf Se Verpackungsform
CN102271915B (zh) * 2008-11-04 2014-11-26 巴斯夫欧洲公司 复合箔作为氧化敏感性聚合物的包装材料的用途，包装氧化敏感性聚合物的方法以及含有所述复合箔的包装
WO2010072640A1 (de) * 2008-12-22 2010-07-01 Basf Se Verfahren zur stabilisierung von polymeren
HUE030062T2 (en) 2010-11-08 2017-04-28 Albireo Ab IBAT inhibitors for the treatment of liver diseases
US8623978B2 (en) 2010-11-23 2014-01-07 Basf Se Process for the preparation of low-peroxide crosslinked vinyllactam polymer
EP2511331A1 (de) 2011-04-12 2012-10-17 Basf Se Peroxidarmes Polymer enthaltend Phosphorverbindung
US9023931B2 (en) 2011-04-12 2015-05-05 Basf Se Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound
WO2012140561A1 (en) 2011-04-12 2012-10-18 Basf Se Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound
DE202011005055U1 (de) 2011-04-12 2011-09-12 Basf Se Peroxidarmes Polymer enthaltend Phosphorverbindung
US9260546B2 (en) 2012-08-08 2016-02-16 Basf Se Producing aqueous solutions of vinyllactam polymers and powders thereof
BR112015002465B1 (pt) 2012-08-08 2021-01-19 Basf Se processo para a produção de um polímero de vinil lactama, polímero de vinil lactama obtenível pelo processo, uso do polímero, membrana para purificação de líquidos e gel de cabelo
KR20220082931A (ko) 2014-06-25 2022-06-17 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CA3071285A1 (en) 2017-08-09 2019-02-14 Albireo Ab Cholestyramine granules, oral cholestyramine formulations and use thereof
CN108685164B (zh) * 2018-03-21 2021-01-29 云南中烟工业有限责任公司 降低烟气中co释放量的亚铁配合物添加剂及其制备方法与应用
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
PE20210182A1 (es) 2018-06-20 2021-01-29 Albireo Ab Modificaciones de cristales de odexibat
US10722457B2 (en) * 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) * 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
SG11202102685QA (en) * 2018-09-19 2021-04-29 Isp Investments Llc Peroxide stable polymer composition and process for its preparation and applications thereof
WO2020146691A1 (en) 2019-01-11 2020-07-16 Encapsys, Llc Incorporation of chitosan in microcapsule wall

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2439196C3 (de) * 1974-08-16 1978-11-02 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Polyvinylpyrrolidon
DE3532747A1 (de) * 1985-09-13 1987-03-26 Basf Ag Verfahren zur herstellung von polyvinylpyrrolidon
CA2075481C (en) * 1990-02-27 2006-03-28 Peter Gyulai Hydrogen peroxide destroying compositions and methods of making and using same
US5364601A (en) 1992-12-30 1994-11-15 Bausch & Lomb Incorporated Treating of contact lenses with compositions comprising PVP-H202
DE19640365A1 (de) * 1996-09-30 1998-04-02 Basf Ag Polymer-Wasserstoffperoxid-Komplexe

Also Published As

Publication number Publication date
EP1083884A1 (de) 2001-03-21
DE19915420A1 (de) 2000-10-12
CN1313760A (zh) 2001-09-19
DE50000639D1 (de) 2002-11-21
ES2185584T3 (es) 2003-05-01
JP2002541091A (ja) 2002-12-03
US6592900B1 (en) 2003-07-15
ATE226066T1 (de) 2002-11-15
DK1083884T3 (da) 2002-11-04
EP1083884B1 (de) 2002-10-16
WO2000059478A1 (de) 2000-10-12
CN1174743C (zh) 2004-11-10

Similar Documents

Publication Publication Date Title
PT1083884E (pt) Processo para a estabilizacao de composicoes de polivinil-pirrolidona
WO2002080976A3 (en) Hsa-free formulations of interferon-beta
WO2002076404A3 (en) Fatty alcohol drug conjugates
HK1024182A1 (en) Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
HUP0402179A3 (en) Poxvirus containing formulations and process for preparing stable, poxvirus containing compositions
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
AU2002316811A1 (en) Stable formulation of modified glp-1
MXPA05002814A (es) Formulacion para agentes lipofilicos.
AU2001295017A1 (en) Solid dose nanoparticulate compositions
GB9409778D0 (en) Compositions
EP1145719A3 (en) Use a ferrous salt for inhibiting oxidative degradation of pharmaceutical formulations
BG106046A (en) Pharmaceutical compositions of ertythropoietin
AU4155897A (en) Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
YU8701A (sh) Nova oralna kompozicija
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
WO2000053231A3 (en) Fatty acid-anticancer conjugates and uses thereof
AU2003219046A1 (en) Cationic polymers and the use thereof in cosmetic formulations
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
AU2003296602A1 (en) Quaternary compounds comprising propolis as the active substance
NZ528544A (en) Formulations comprising entrapped active ingredients and uses thereof
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
WO2003053365A3 (en) Syn3 compositions and methods
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
AU2001287489A1 (en) New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments
HRP20020071B1 (en) Pharmaceutical composition and preparation thereof